Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Enanta notes AbbVie granted FDA priority review for Hep C combo regimen
Enanta notes AbbVie granted FDA priority review for Hep C combo regimen
Enanta notes AbbVie granted FDA priority review for Hep C combo regimen
Submitted by
admin
on June 13, 2014 - 6:44pm
Source:
Yahoo/Fly on the Wall
News Tags:
AbbVie
Enanta Pharmaceuticals
FDA
hepatitis C
ABT-450
Headline:
Enanta notes AbbVie granted FDA priority review for Hep C combo regimen
Do Not Allow Advertisers to Use My Personal information
